STOCK TITAN

AORT insider plans to sell 12,500 shares via RBC Capital Markets

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Artivion, Inc. (AORT) shows a proposed sale of 12,500 common sharesRBC Capital Markets with an aggregate market value of $528,991. The filing lists the approximate sale date as 08/15/2025 and the shares outstanding as 47,183,658. The shares were acquired in open-market purchases: 5,000 shares on 11/13/2019 and 7,500 shares on 11/13/2019 (with payment dated 09/16/2020 for the second lot). The filer reports no sales in the past three months and makes the standard representation about material undisclosed information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider notice to sell a small block of shares; immaterial to company valuation based on disclosed figures.

The Form 144 documents a proposed sale of 12,500 common shares valued at $528,991, representing a very small fraction of the 47,183,658 shares outstanding. The shares were purchased in the open market in 2019 (two lots) and no sales occurred in the prior three months. This filing is procedural under Rule 144 to comply with resale notice requirements and, on its face, does not indicate corporate events or new financial information.

TL;DR: Disclosure meets regulatory notice requirements; provides limited governance signal beyond routine insider liquidity.

The notice identifies the broker (RBC Capital Markets) and affirms the filer is not aware of undisclosed material information. No relationship to the issuer is specified in the provided content. Absence of recent sales and disclosure of acquisition dates satisfy standard transparency expectations for an insider or affiliate planning a sale, but the form itself conveys no governance change or material corporate action.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Artivion (AORT) Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 12,500 common shares through RBC Capital Markets with aggregate market value $528,991 and approximate sale date 08/15/2025.

How many shares of Artivion are outstanding according to the Form 144?

The filing lists 47,183,658 shares outstanding for the issuer.

When and how were the shares being sold acquired?

The shares were acquired in open-market purchases: 5,000 shares on 11/13/2019 and 7,500 shares on 11/13/2019 (with payment for the second lot dated 09/16/2020), paid by check.

Does the Form 144 report any securities sold in the past three months for AORT?

The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker handling the proposed Artivion share sale?

The broker named is RBC Capital Markets LLC located at 250 Nicollet Mall, Minneapolis, MN.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.22B
43.29M
4.5%
89.88%
2.32%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW